Tudor Investment Corp
OLMA icon

Tudor Investment Corp’s Olema Pharmaceuticals OLMA Stock Holding History

Tudor Investment Corp’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,745
Closed -$44K – 2791
2023
Q1 		$44K Sell
12,745
-7,131
-36% -$29.1K ﹤0.01% 2290
2022
Q4 		$49K Hold
19,876
– – ﹤0.01% 2247
2022
Q3 		$55K Buy
+19,876
New +$84.3K ﹤0.01% 2185

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Tudor Investment Corp's OLMA Position: Q2 2023 in Review

Tudor Investment Corp sold out of Olema Pharmaceuticals (OLMA) in Q2 2023, closing a stake of 12,745 shares — an estimated $44K sold.

Tudor Investment Corp first reported a position in OLMA in Q3 2022 and held it in 3 quarters. The position peaked at $55K in Q3 2022. 87 funds tracked by Wall St. Rank hold OLMA as of Q2 2023.

  • Tudor Investment Corp reported no remaining Olema Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 12,745 Olema Pharmaceuticals shares in Q2 2023, an estimated $44K.
  • Tudor Investment Corp first reported a position in Olema Pharmaceuticals in Q3 2022 and held it in 3 quarters.
  • Tudor Investment Corp's Olema Pharmaceuticals position peaked at $55K in Q3 2022.
  • 87 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.